Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 18
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

    This project is aimed at understanding the morphological differences between two species of Sphingidae...

    Probiotics for plants? Fighting insects by boosting corn immune systems

    Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

    Dental and Jaw Joint Pathology of the Walrus

    Tooth and jaw (temporomandibular) joint (TMJ) diseases are common in certain wildlife species and may be...

    Backer Badge Funded